Add-on Acquisition • Consumer Products

Procter & Gamble Acquires DDF Skincare

On January 22, 2007, Procter & Gamble acquired consumer products company DDF Skincare from North Castle Partners and Easton Capital Investment Group

Acquisition Context
  • This is Procter & Gamble’s 10th transaction in the Consumer Products sector.
  • This is Procter & Gamble’s 11th transaction in the United States.
  • This is Procter & Gamble’s 2nd transaction in Ohio.

Explore All 2386 Add-on Acquisition Consumer Products Deals - Search the Database Free


M&A Deal Summary

Date January 22, 2007
Target DDF Skincare
Sector Consumer Products
Buyer(s) Procter & Gamble
Sellers(s) North Castle Partners
Easton Capital Investment Group
Deal Type Add-on Acquisition

Target Company

DDF Skincare

Cincinnati, Ohio, United States
Doctor's Dermatologic Formula (DDF) formulates and markets therapeutic skincare "cosmeceutical" products providing the most comprehensive solutions available without a prescription.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Procter & Gamble

Cincinnati, Ohio, United States

Category Company
Founded 1837
Sector Consumer Products
Employees108,000
Revenue 84.0B USD (2024)
DESCRIPTION
Entrance to Procter & Gamble's corporate headquarters in Cincinnati, Ohio.
Entrance to Procter & Gamble's corporate headquarters in Cincinnati, Ohio.

Procter & Gamble is a producer of branded consumer packaged goods. Procter & Gamble was formed in 1837 and is based in Cincinnati, Ohio.


Deal Context for Buyer #
Overall 12 of 29
Sector: Consumer Products 10 of 23
Type: Add-on Acquisition 10 of 25
State: Ohio 2 of 2
Country: United States 11 of 26
Year: 2007 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-09-26 Sure Antiperspirants

United States

Sure Antiperspirants is a brand of deodorants formed in 1973.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-10-04 PHA Technology

United States

A Polyhydroxyalkanoate (PHA) technology. Procter & Gamble developed the technology through more than a decade of research, resulting in a highly functional and cost effective material.

Sell -

Seller Profiles 2

SELLER

North Castle Partners

Greenwich, Connecticut, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1997
Size Middle-Market
Type Sector Focused
DESCRIPTION

North Castle Partners is a specialist private equity firm that targets investments in consumer-driven product and service businesses. North Castle seeks control investments in companies that benefit from consumers looking to live 'healthier' lives as well as businesses that benefit from the baby boomer population. Specific areas of interest include aesthetics and personal care, consumer health, fitness and recreation, home and leisure, and nutrition. North Castle was formed in 1997 and is based in Greenwich, Connecticut.


Deal Context for Seller #
Overall 8 of 25
Sector: Consumer Products 3 of 10
Type: Add-on Acquisition 5 of 15
State: Ohio 1 of 1
Country: United States 7 of 23
Year: 2007 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-11 Avalon Natural Products

Boulder, Colorado, United States

Avalon is a provider of natural products. Categories include skin care, hair care, bath and body and sun care.

Sell $120M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-07-03 Performance Bicycle

Chico, California, United States

Performance Bicycle is an independent bicycle dealer and direct marketer of bicycles and cycling accessories in the United States. Performance Bicycle is based in Chico, California.

Buy -
SELLER

Easton Capital Investment Group

New York, New York, United States

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 2000
PE ASSETS 200M USD
Size Small
Type Sector Focused
DESCRIPTION

Easton Capital Investment Group is a private investment firm that targets early-stage venture capital to later-stage growth capital investments. Easton will consider opportunities across a range of industries but generally invests in the healthcare industry, including biopharmaceuticals, drug delivery, medical devices, and healthcare services. Easton looks to commit $0.50 to $10 million per transaction. Easton Capital was formed in 2000 and is based in New York, New York.


Deal Context for Seller #
Overall 9 of 21
Sector: Consumer Products 1 of 1
Type: Add-on Acquisition 4 of 9
State: Ohio 1 of 1
Country: United States 9 of 21
Year: 2007 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Quasar

Albuquerque, New Mexico, United States

Quasar is an established leader in Ultrasonic Resonant Inspection, an emerging technology in the field of non-destructive inspection (NDI) using sophisticated pattern-recognition software to analyze ultrasonic resonance measurements on the item being inspected. Quasar was acquired by Illinois Tool Works in 2007, generating proceeds to Easton 2.4x its initial cost.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-02-13 Trellis Bioscience

South San Francisco, California, United States

Trellis Bioscience is a biotechnology company that developed a breakthrough technology platform for discovery and selection of very rare cells that produce ideal proteins such as antibodies, selected for specificity, selectivity, affinity, secretion rate and other desired characteristics.

Buy -